Vitamin D for Longevity & Health

Vitamin D (cholecalciferol, or D3) is a fat-soluble hormone precursor your body makes in skin exposed to sunlight and absorbs in small amounts from food. It governs calcium balance, bone mineralization, and modulates immune function. Because so much of modern life happens indoors, low vitamin D status is genuinely common: depending on the cut-off and latitude, a substantial share of adults fall below 50 nmol/L (20 ng/mL), and outright deficiency clusters in older adults, people with darker skin, and those at high latitudes.

The honest summary up front: correcting true deficiency clearly matters for bone and likely for respiratory infection risk, but supplementing people who are already replete has produced largely null results in the biggest mortality and disease-prevention trials. Vitamin D is a floor to maintain, not a lever to push ever higher.

How it works

When UVB sunlight hits the skin, it converts 7-dehydrocholesterol into vitamin D3. D3 (from sun, food, or supplements) is then hydroxylated in the liver to 25-hydroxyvitamin D, or 25(OH)D — the circulating storage form measured on blood tests and the best marker of your status. The kidney converts this into the active hormone, 1,25-dihydroxyvitamin D (calcitriol), which is tightly regulated and not a useful status marker.

Calcitriol binds the vitamin D receptor (VDR), expressed in intestine, bone, immune cells, and many other tissues. Its best-established job is increasing intestinal calcium and phosphate absorption to support bone mineralization; deficiency causes rickets in children and osteomalacia in adults. VDR signaling also influences innate immune responses, which is the mechanistic basis for the infection findings below.

Evidence by use-case

The evidence is strongest where a deficiency is being corrected and weakest where it isn’t. For bone and falls/fractures, vitamin D with adequate calcium reduces deficiency-related bone disease, but routine high-dose supplementation in replete older adults has not consistently cut fractures — and very high monthly bolus dosing has paradoxically increased falls. For respiratory infection, a large individual-participant meta-analysis found a modest protective effect, concentrated in deeply deficient people taking daily or weekly (not bolus) doses. For all-cause mortality and cancer/cardiovascular prevention, the two largest trials (VITAL in the US, D-Health in Australia) were essentially null in generally replete populations; D-Health even raised a cautionary signal on cancer mortality. For autoimmune disease, VITAL’s ancillary analysis suggested a possible reduction in autoimmune incidence, but this remains a hypothesis needing confirmation.

Protocol & dosing

For most adults, typical maintenance doses run 800–2,000 IU/day of D3, with deficiency correction sometimes using higher short-term doses under clinical guidance. A common target for 25(OH)D is roughly 50–75 nmol/L (20–30 ng/mL); pushing well above this has not shown added benefit and adds risk. The only way to dose rationally is to test 25(OH)D rather than guess.

• D3 vs D2: D3 (cholecalciferol) raises and sustains 25(OH)D more effectively than D2 (ergocalciferol) and is generally preferred.
• Cofactors: vitamin D works with calcium and magnesium; many people pair D3 with vitamin K2 and adequate magnesium, though the hard outcome evidence for K2 co-supplementation is limited.
• Dosing pattern: daily or weekly dosing appears more favorable than large infrequent bolus doses, which have underperformed and, at extreme monthly doses, increased falls.
• Toxicity: the tolerable upper intake level for adults is generally cited as 4,000 IU/day; toxicity (hypercalcemia) is rare but real with sustained megadoses, typically when 25(OH)D climbs well above 125 nmol/L.

Risks & common myths

“More is better” is the central myth. Above the point of repletion, higher 25(OH)D has not delivered better outcomes in randomized trials, and the dose-response can turn against you. In a randomized trial, older adults given very high monthly vitamin D had more falls than those on a modest dose — the megadose fall paradox.

Supplements are not a tidy substitute for the whole picture. Sun exposure, body weight, baseline status, and dosing pattern all shape the result. And the headline mortality and cancer/cardiovascular trials — VITAL and D-Health — were largely null in populations that were mostly replete to begin with. That is the key nuance: these trials argue against routine supplementation for life-extension in already-sufficient people, not against correcting genuine deficiency. D-Health’s authors even invoked the precautionary principle given a possible cancer-mortality signal at high monthly dosing.

Who it’s for

The people most likely to benefit are those who are actually deficient: older adults, people with limited sun exposure or who cover up, those with darker skin at high latitudes, people with malabsorption or obesity, and anyone with a documented low 25(OH)D. For replete, sun-exposed younger adults, routine high-dose supplementation has the weakest case.

Where to get it

If you and your clinician decide supplementation is appropriate, a D3 product (often paired with K2) is the usual choice: vitamin D3 (with K2) on iHerb. Confirm the dose against your blood test rather than defaulting to the highest available.

Sources

• Manson JE et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease (VITAL). N Engl J Med 2018. PMID 30415629. DOI
• Neale RE et al. The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality. Lancet Diabetes Endocrinol 2022. PMID 35026158. DOI
• Martineau AR et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017. PMID 28202713. DOI
• Bischoff-Ferrari HA et al. Monthly High-Dose Vitamin D Treatment for the Prevention of Functional Decline: A Randomized Clinical Trial. JAMA Intern Med 2016. PMID 26747333. DOI
• Rahman ST et al. Effects of Vitamin D Supplementation on Telomere Length: An Analysis of Data from the Randomised Controlled D-Health Trial. J Nutr Health Aging 2023. PMID 37702332. DOI